Sfoglia per Rivista FUTURE ONCOLOGY
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?
2017-01-01 Fabi, Alessandra; Giannarelli, Diana; Moscetti, Luca; Santini, Daniele; Zambelli, Alberto; Laurentiis, Michelino De; Caruso, Michele; Generali, Daniele; Valle, Enrichetta; Leonardi, Vita; Cannita, Katia; Arpino, Grazia; Filippelli, Gianfranco; Ferretti, Gianluigi; Giampaglia, Marianna; Montemurro, Filippo; Nisticò, Cecilia; Gasparro, Simona; Cognetti, Francesco
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer
2019-01-01 Mennini, Fs; Marcellusi, A; Fabiano, G; Rimassa, L; Santoro, A; Personeni, N
Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design
2020-01-01 Kelley, Robin Kate; W Oliver, Jennifer; Hazra, Saswati; Benzaghou, Fawzi; Yau, Thomas; Cheng, Ann-Lii; Rimassa, Lorenza
Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib
2019-01-01 Personeni, N; Pressiani, T; Rimassa, L
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer
2016-01-01 Veccia, Antonello; Caffo, Orazio; De Giorgi, Ugo; Di Lorenzo, Giuseppe; Ortega, Cinzia; Scognamiglio, Florinda; Aieta, Michele; Facchini, Gaetano; Mansueto, Giovanni; Mattioli, Rodolfo; Procopio, Giuseppe; Zagonel, Vittorina; D'Angelo, Alessandro; Spizzo, Gilbert; Bortolus, Roberto; Donini, Maddalena; Lo Re, Giovanni; Massari, Francesco; Vicario, Giovanni; Zucali, Paolo A; Alesini, Daniele; Bonetti, Andrea; Mucciarini, Claudia; Nicodemo, Maurizio; Berruti, Alfredo; Fratino, Lucia; Lodde, Michele; Messina, Caterina; Perin, Alessandra; Santini, Daniele; Sava, Teodoro; Tucci, Marcello; Basso, Umberto; Maines, Francesca; Burgio, Luca S; Galligioni, Enzo
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study
2020-01-01 Bossi, P.; Peris, K.; Calzavara-Pinton, P.; Queirolo, P.; Alfieri, S.; Palla, M.; Rossi, M. T.; Spagnolo, F.; Tambone, S.; Astolfi, C.; Ascierto, P. A.
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma
2013-01-01 Orlandi, E; Tomatis, S; Potepan, P; Bossi, P; Mongioj, V; Carrara, M; Palazzi, M; Franceschini, M; Bergamini, C; Locati, L; Iannacone, E; Guzzo, M; Ibba, T; Crippa, F; Licitra, L; Pignoli, E; Fallai, C
Do you agree with populations that have been defined as 'noncandidates' to receiving platinum?
2013-01-01 del Campo, Jm; Sehouli, J; Lorusso, D
Effect of the number of biopsy cores on prostate cancer detection and staging
2010-01-01 Lughezzani, G; Sun, M; Budaus, L; Thuret, R; Shariat, Sf; Perrotte, P; Karakiewicz, Pi
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
2020-01-01 Bekaii-Saab, Tanios S; Valle, Juan W; Cutsem, Eric Van; Rimassa, Lorenza; Furuse, Junji; Ioka, Tatsuya; Melisi, Davide; Macarulla, Teresa; Bridgewater, John; Wasan, Harpreet; Borad, Mitesh J; Abou-Alfa, Ghassan K; Jiang, Ping; Lihou, Christine F; Zhen, Huiling; Asatiani, Ekaterine; Féliz, Luis; Vogel, Arndt
Is this efficacy in partially platinum-sensitive patients observed at any relapse?
2013-01-01 Sehouli, J; del Campo, Jm; Lorusso, D
It is time to start active treatment in senior adults with prostate cancer
2014-01-01 Van den Broeck, T; Tosco, L; Joniau, S
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)
2023-01-01 Abou-Alfa, Ghassan K; Lau, George; Kudo, Masatoshi; Chan, Stephen L; Kelley, Robin Kate; Furuse, Junji; Sukeepaisarnjaroen, Wattana; Kang, Yoon Koo; Dao, Tu Van; De Toni, Enrico N; Rimassa, Lorenza; Breder, Valeriy; Vasilyev, Alexander; Heurgué, Alexandra; Tam, Vincent C; Mody, Kabir; Thungappa, Satheesh Chiradoni; Ostapenko, Yurii; Yau, Thomas; Azevedo, Sergio; Varela, María; Cheng, Ann-Lii; Qin, Shukui; Galle, Peter R; Ali, Sajid; Gupta, Charu; Makowsky, Mallory; Kurland, John F; Negro, Alejandra; Sangro, Bruno
Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review
2014-01-01 Orlandi, E; Takanen, S; Giandini, T; Iannacone, E; Fontanella, W; Locati, L; Carrara, M; Bossi, P; Bergamini, C; Granata, R; Tombolini, V; Ibba, T; Licitra, L; Pignoli, E; Fallai, C
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough
2017-01-01 Fornaro, L; Fanotto, V; Musettini, G; Bordonaro, R; Rimassa, L; Vivaldi, C; Fontanella, C; Leone, F; Giampieri, R; Rosati, G; Lencioni, M; Santini, D; Di Donato, S; Tomasello, G; Brunetti, O; Pietrantonio, F; Bergamo, F; Scartozzi, M; Avallone, A; Lutrino, Se; Melisi, D; Antonuzzo, L; Pellegrino, A; Gerratana, L; Cordio, S; Vasile, E; Aprile, G
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer
2019-01-01 Rossi, S; Finocchiaro, G; Di Noia, V; Bonomi, M; Cerchiaro, E; De Rose, F; Franceschini, D; Navarria, P; Ceresoli, Gl; Beretta, Gd; D'Argento, E; Scorsetti, M; Santoro, A; Toschi, L
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy
2019-01-01 Bossi, P.; Botta, L.; Bironzo, P.; Sonetto, C.; Musettini, G.; Sbrana, A.; Di Giannantonio, V.; Locati, L. D.; Di Maio, M.; Antonuzzo, A.
Targeted therapy for thymic epithelial tumors: a new horizon ? Review of the literature and two cases reports
2015-01-01 Simonelli, M; Zucali, PAOLO ANDREA; Suter, M B; Lorenzi, E; Rubino, L; Fatuzzo, G; Alloisio, M; Santoro, A
Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma
2013-01-01 Rimassa, L; Personeni, N; Simonelli, M; Santoro, A
Trabectedin mechanism of action: what's new?
2013-01-01 D'Incalci, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? | 1-gen-2017 | Fabi, Alessandra; Giannarelli, Diana; Moscetti, Luca; Santini, Daniele; Zambelli, Alberto; Laurentiis, Michelino De; Caruso, Michele; Generali, Daniele; Valle, Enrichetta; Leonardi, Vita; Cannita, Katia; Arpino, Grazia; Filippelli, Gianfranco; Ferretti, Gianluigi; Giampaglia, Marianna; Montemurro, Filippo; Nisticò, Cecilia; Gasparro, Simona; Cognetti, Francesco | |
| Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer | 1-gen-2019 | Mennini, Fs; Marcellusi, A; Fabiano, G; Rimassa, L; Santoro, A; Personeni, N | |
| Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design | 1-gen-2020 | Kelley, Robin Kate; W Oliver, Jennifer; Hazra, Saswati; Benzaghou, Fawzi; Yau, Thomas; Cheng, Ann-Lii; Rimassa, Lorenza | |
| Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib | 1-gen-2019 | Personeni, N; Pressiani, T; Rimassa, L | |
| Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer | 1-gen-2016 | Veccia, Antonello; Caffo, Orazio; De Giorgi, Ugo; Di Lorenzo, Giuseppe; Ortega, Cinzia; Scognamiglio, Florinda; Aieta, Michele; Facchini, Gaetano; Mansueto, Giovanni; Mattioli, Rodolfo; Procopio, Giuseppe; Zagonel, Vittorina; D'Angelo, Alessandro; Spizzo, Gilbert; Bortolus, Roberto; Donini, Maddalena; Lo Re, Giovanni; Massari, Francesco; Vicario, Giovanni; Zucali, Paolo A; Alesini, Daniele; Bonetti, Andrea; Mucciarini, Claudia; Nicodemo, Maurizio; Berruti, Alfredo; Fratino, Lucia; Lodde, Michele; Messina, Caterina; Perin, Alessandra; Santini, Daniele; Sava, Teodoro; Tucci, Marcello; Basso, Umberto; Maines, Francesca; Burgio, Luca S; Galligioni, Enzo | |
| Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study | 1-gen-2020 | Bossi, P.; Peris, K.; Calzavara-Pinton, P.; Queirolo, P.; Alfieri, S.; Palla, M.; Rossi, M. T.; Spagnolo, F.; Tambone, S.; Astolfi, C.; Ascierto, P. A. | |
| Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma | 1-gen-2013 | Orlandi, E; Tomatis, S; Potepan, P; Bossi, P; Mongioj, V; Carrara, M; Palazzi, M; Franceschini, M; Bergamini, C; Locati, L; Iannacone, E; Guzzo, M; Ibba, T; Crippa, F; Licitra, L; Pignoli, E; Fallai, C | |
| Do you agree with populations that have been defined as 'noncandidates' to receiving platinum? | 1-gen-2013 | del Campo, Jm; Sehouli, J; Lorusso, D | |
| Effect of the number of biopsy cores on prostate cancer detection and staging | 1-gen-2010 | Lughezzani, G; Sun, M; Budaus, L; Thuret, R; Shariat, Sf; Perrotte, P; Karakiewicz, Pi | |
| FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements | 1-gen-2020 | Bekaii-Saab, Tanios S; Valle, Juan W; Cutsem, Eric Van; Rimassa, Lorenza; Furuse, Junji; Ioka, Tatsuya; Melisi, Davide; Macarulla, Teresa; Bridgewater, John; Wasan, Harpreet; Borad, Mitesh J; Abou-Alfa, Ghassan K; Jiang, Ping; Lihou, Christine F; Zhen, Huiling; Asatiani, Ekaterine; Féliz, Luis; Vogel, Arndt | |
| Is this efficacy in partially platinum-sensitive patients observed at any relapse? | 1-gen-2013 | Sehouli, J; del Campo, Jm; Lorusso, D | |
| It is time to start active treatment in senior adults with prostate cancer | 1-gen-2014 | Van den Broeck, T; Tosco, L; Joniau, S | |
| Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer) | 1-gen-2023 | Abou-Alfa, Ghassan K; Lau, George; Kudo, Masatoshi; Chan, Stephen L; Kelley, Robin Kate; Furuse, Junji; Sukeepaisarnjaroen, Wattana; Kang, Yoon Koo; Dao, Tu Van; De Toni, Enrico N; Rimassa, Lorenza; Breder, Valeriy; Vasilyev, Alexander; Heurgué, Alexandra; Tam, Vincent C; Mody, Kabir; Thungappa, Satheesh Chiradoni; Ostapenko, Yurii; Yau, Thomas; Azevedo, Sergio; Varela, María; Cheng, Ann-Lii; Qin, Shukui; Galle, Peter R; Ali, Sajid; Gupta, Charu; Makowsky, Mallory; Kurland, John F; Negro, Alejandra; Sangro, Bruno | |
| Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review | 1-gen-2014 | Orlandi, E; Takanen, S; Giandini, T; Iannacone, E; Fontanella, W; Locati, L; Carrara, M; Bossi, P; Bergamini, C; Granata, R; Tombolini, V; Ibba, T; Licitra, L; Pignoli, E; Fallai, C | |
| Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough | 1-gen-2017 | Fornaro, L; Fanotto, V; Musettini, G; Bordonaro, R; Rimassa, L; Vivaldi, C; Fontanella, C; Leone, F; Giampieri, R; Rosati, G; Lencioni, M; Santini, D; Di Donato, S; Tomasello, G; Brunetti, O; Pietrantonio, F; Bergamo, F; Scartozzi, M; Avallone, A; Lutrino, Se; Melisi, D; Antonuzzo, L; Pellegrino, A; Gerratana, L; Cordio, S; Vasile, E; Aprile, G | |
| Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer | 1-gen-2019 | Rossi, S; Finocchiaro, G; Di Noia, V; Bonomi, M; Cerchiaro, E; De Rose, F; Franceschini, D; Navarria, P; Ceresoli, Gl; Beretta, Gd; D'Argento, E; Scorsetti, M; Santoro, A; Toschi, L | |
| Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy | 1-gen-2019 | Bossi, P.; Botta, L.; Bironzo, P.; Sonetto, C.; Musettini, G.; Sbrana, A.; Di Giannantonio, V.; Locati, L. D.; Di Maio, M.; Antonuzzo, A. | |
| Targeted therapy for thymic epithelial tumors: a new horizon ? Review of the literature and two cases reports | 1-gen-2015 | Simonelli, M; Zucali, PAOLO ANDREA; Suter, M B; Lorenzi, E; Rubino, L; Fatuzzo, G; Alloisio, M; Santoro, A | |
| Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma | 1-gen-2013 | Rimassa, L; Personeni, N; Simonelli, M; Santoro, A | |
| Trabectedin mechanism of action: what's new? | 1-gen-2013 | D'Incalci, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile